Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed ...
Seres Therapeutics, Inc.: Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed primary efficacy endpoint of reduction in bloodstream inf ...
Demilked on MSN21h
“What Exactly Causes Itching”: 25 Mysteries Of The Human Body
Medical mysteries of the human body that have modern-day doctors stumped. The post “What Exactly Causes Itching”: 25 ...
Semisynthetic bile acid shows promise in reducing gut inflammation
A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation.